首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   3511020篇
  免费   296621篇
  国内免费   15969篇
耳鼻咽喉   47475篇
儿科学   112314篇
妇产科学   91665篇
基础医学   559561篇
口腔科学   94389篇
临床医学   324325篇
内科学   619445篇
皮肤病学   91432篇
神经病学   302822篇
特种医学   135588篇
外国民族医学   392篇
外科学   530743篇
综合类   106497篇
现状与发展   23篇
一般理论   2321篇
预防医学   305083篇
眼科学   79636篇
药学   241237篇
  27篇
中国医学   10504篇
肿瘤学   168131篇
  2021年   55761篇
  2020年   35541篇
  2019年   58672篇
  2018年   72483篇
  2017年   55271篇
  2016年   60887篇
  2015年   74900篇
  2014年   109260篇
  2013年   175059篇
  2012年   100645篇
  2011年   101865篇
  2010年   119649篇
  2009年   122972篇
  2008年   87484篇
  2007年   90788篇
  2006年   100955篇
  2005年   96012篇
  2004年   97038篇
  2003年   87392篇
  2002年   76927篇
  2001年   107619篇
  2000年   100945篇
  1999年   99658篇
  1998年   65804篇
  1997年   63632篇
  1996年   61289篇
  1995年   56922篇
  1994年   51064篇
  1993年   47642篇
  1992年   70893篇
  1991年   67998篇
  1990年   64515篇
  1989年   62926篇
  1988年   58480篇
  1987年   57105篇
  1986年   54519篇
  1985年   54378篇
  1984年   49332篇
  1983年   44954篇
  1982年   42068篇
  1981年   39641篇
  1980年   37261篇
  1979年   40844篇
  1978年   35981篇
  1977年   32509篇
  1976年   30362篇
  1975年   28605篇
  1974年   30096篇
  1973年   28978篇
  1972年   27102篇
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
91.
92.
Troppmair  Teresa  Egger  J.  Krösbacher  A.  Zanvettor  A.  Schinnerl  A.  Neumayr  A.  Baubin  M. 《Der Anaesthesist》2022,71(4):272-280
Die Anaesthesiologie - Die Qualität eines Rettungssystems zeichnet sich auch durch den effizienten Einsatz seiner personellen und Fahrzeugressourcen aus. So können im berechtigten Fall...  相似文献   
93.
94.
Cutaneous leiomyomas are rare benign smooth‐muscle tumors. These lesions are distinguished based on their cell of origin and are subclassified as pilar leiomyoma, angioleiomyoma, and genital‐type leiomyoma. Nipple leiomyoma is the least common genital‐type leiomyoma, arising from the dartoic muscle cell of the nipple. Histologic examination of the lesion is necessary for definitive diagnosis, and these uncommon tumors can pose a diagnostic challenge. We describe herein a series of six nipple leiomyomas with a spectrum of histologic appearances.  相似文献   
95.
96.
97.
Gold nanoparticles (Au NPs) hold great promise in food, industrial and biomedical applications due to their unique physicochemical properties. However, influences of the gastrointestinal tract (GIT), a likely route for Au NPs administration, on the physicochemical properties of Au NPs has been rarely evaluated. Here, we investigated the influence of GIT fluids on the physicochemical properties of Au NPs (5, 50, and 100?nm) and their implications on intestinal epithelial permeability in vitro. Au NPs aggregated in fasted gastric fluids and generated hydroxyl radicals in the presence of H2O2. Cell studies showed that GIT fluids incubation of Au NPs affected the cellular uptake of Au NPs but did not induce cytotoxicity or disturb the intestinal epithelial permeability.  相似文献   
98.
Introduction: The Hedgehog (HH) pathway constitutes a collection of signaling molecules which critically influence embryogenesis. In adults, however, the HH pathway remains integral to the proliferation, maintenance, and apoptosis of adult stem cells including hematopoietic stem cells.

Areas covered: We discuss the current understanding of the HH pathway as it relates to normal hematopoiesis, the pathology of acute myeloid leukemia (AML), the rationale for and data from combination therapies including HH pathway inhibitors, and ultimately the prospects that might offer promise in targeting this pathway in AML.

Expert opinion: Efforts to target the HH pathway have been focused on impeding this disposition and restoring chemosensitivity to conventional myeloid neoplasm therapies. The year 2018 saw the first approval of a HH pathway inhibitor (glasdegib) for AML, though for an older population and in combination with an uncommonly-used therapy. Several other clinical trials with agents targeting modulators of HH signaling in AML and MDS are underway. Further study and understanding of the interplay between the numerous aspects of HH signaling and how it relates to the augmented survival of AML will provide a more reliable substrate for therapeutic strategies in patients with this poor-risk disease.  相似文献   

99.
Adjuvant irradiation is the standard treatment after breast conservative surgery. Normofractionated regimen with an overall treatment time of 5 to 6 weeks is often considered as a limiting factor for irradiation compliance. In order to answer this issue, moderate and more recently extreme hypofractionated protocols appeared. We report here oncological outcomes and toxicity of hypofractionated breast irradiation. After defining the frame of moderate and extreme hypofractionated breast irradiations based on overall treatment time, patient selection criteria were listed. According to their levels of proof, the results of moderate and extreme hypofractionated breast irradiation were analysed. Overall treatment time for moderate hypofractionated breast irradiation ranged from 3 to 4 weeks, while for extreme hypofractionated breast irradiation, it was less than 1 week. For moderate hypofractionated breast irradiation, whole breast irradiation was currently performed with or without lymph node irradiation. Moderate hypofractionated breast irradiation has proven to be as safe and as efficient as normofractionated breast irradiation with level IA evidence. For extreme hypofractionated breast irradiation, phase III randomized trials confirmed that accelerated partial breast irradiation was non-inferior in terms of local control compared to normofractionated whole breast irradiation (with external beam radiation therapy and multicatheter brachytherapy), with similar acute and late toxicity. While the use of intraoperative breast irradiation remains under debate, new very accelerated partial breast irradiation (overall treatment time not exceeding 2 days) protocols emerged with encouraging results. Accelerated partial breast irradiation is warranted for extreme hypofractionated breast irradiation and is indicated for low-risk breast cancers. Moderate and extreme hypofractionated breast irradiation regimens are validated and can be routinely proposed according to patient selection criteria.  相似文献   
100.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号